Annalee Nguyen

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Applied Biosystems, LLC, The University of Texas System, Synthetic Biologics, Inc.. Active years: 2011-2026.

USPTO Granted Patents = 9 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 63(Granted Patents)

Company Filing History:

5 out of 532

Applied Biosystems, LLC

patents

4 out of 5,630

The University of Texas System

patents

3 out of 39

Synthetic Biologics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649772 - HIGH AFFINITY ENGINEERED T-CELL RECEPTORS TARGETING CMV INFECTED CELLS (2026-06-09),

2. 10526400 - Humanized pertussis antibodies and used thereof (2020-01-07),

3. 10501780 - Compositions for in situ nucleic acid analysis (2019-12-10),

4. 10035846 - Humanized pertussis antibodies and uses thereof (2018-07-31),

5. 9512204 - Humanized pertussis antibodies and uses thereof (2016-12-06),

6. 9279152 - Sample preparation for in situ nucleic acid analysis, methods and compositions therefor (2016-03-08),

7. 8828664 - Sample preparation for in situ nucleic acid analysis, methods and compositions therefor (2014-09-09),

8. 8288106 - Sample preparation for in situ nucleic acid analysis, methods and compositions therefor (2012-10-16),

9. 7964350 - Sample preparation for in situ nucleic acid analysis (2011-06-21),

Title: Annalee Nguyen: Innovative Inventor in Antibody Technology

Introduction

Annalee Nguyen, an accomplished inventor based in Austin, TX, has made significant contributions to the field of biotechnology with a focus on antibody innovation. With a total of 8 patents to her name, she has exemplified the spirit of innovation that drives progress in medical science.

Latest Patents

Among her latest patents is the invention titled "Humanized pertussis antibodies and used thereof." This groundbreaking invention pertains to humanized antibodies that bind to the toxin protein, offering new therapeutic avenues for treatment. The enhanced humanized 1B7 and 11E6 antibodies are particularly noteworthy for their specificity in targeting the toxin protein.

Another remarkable patent is for "Compositions for in situ nucleic acid analysis." This invention outlines sample preparation processes for RNA or DNA analysis that can be executed rapidly without the need for extensive sample processing. The methods allow for high throughput analysis in as little as seven minutes at room temperature, making it suitable for manual or robotic processing.

Career Highlights

Throughout her career, Annalee has demonstrated an unwavering commitment to innovation. She has held key positions with prominent organizations, including Applied Biosystems, LLC, and the University of Texas System. Her work has helped advance the field of molecular biology, positioning her as a leader among contemporary inventors.

Collaborations

In her journey of innovation, Annalee has collaborated with notable colleagues such as Richard A. Fekete and Jennifer A. Maynard. These partnerships have fostered a creative environment that has led to the development of her impactful inventions.

Conclusion

Annalee Nguyen's contributions to biotechnology, particularly in antibody technology and nucleic acid analysis, exemplify her dedication to advancing scientific knowledge. With her innovative patents and collaborative spirit, she continues to play a pivotal role in the evolution of medical treatments and diagnostics.